The anti-inflammatory activity of standard aqueous stem bark extract of mangifera indica L. As evident in inhibition of group IA sPLA2

Anais da Academia Brasileira de Ciencias

Volumn 88, Issue 1, 2016, Pages 197-209

  Dhananjaya, Bhadrapura Lakkappa ^a,b   Shivalingaiah, Sudharshan ^a  

^a ADICHUNCHANAGIRI INSTITUTE OF MEDICAL SCIENCES   (India)

^b JAIN UNIVERSITY   (India)

Author keywords

Anti inflammatory; Drug; Inhibition; Plants; Pro inflammatory; Secretory phospholipase A2

Indexed keywords

ANTIINFLAMMATORY AGENT; PHOSPHOLIPASE A2 GROUP II; PLANT EXTRACT;

ANIMAL; ANTAGONISTS AND INHIBITORS; BARK; CHEMISTRY; CLASSIFICATION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; EDEMA; HEMOLYSIS; IC50; MANGIFERA; MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; GROUP II PHOSPHOLIPASES A2; HEMOLYSIS; INHIBITORY CONCENTRATION 50; MANGIFERA; MICE; PLANT BARK; PLANT EXTRACTS;

EID: 84960360659     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/0001-3765201620140574     Document Type: Article

References (56)

1. 2. Annu Rev Pharmacol Toxicol 39: 175-189.
2. 2 from Indian cobra (Naja naja naja) venom. Toxicon 27: 861-873.
3. 2 and arthritis. Arthritis Rheum 36: 190-198.
4. BOMAN HG, KALETTA U. 1957. Chromatography of rattle snake venom, a separation of three phosphodiesterases. Biochim Biophys Acta 24: 619-631.
5. BORGES MH et al. 2000. Effects of aqueous extract of Casearia sylvestris (Flacourtiaceae) on actions of snake venom and bee venoms and on activity of phospholipase A2. Comp Biochem Physiol Biochem Mol Biol 127: 21-30.
6. 2 structure/function, mechanism, and signaling. J Lipid Res 50: S237-S242.
7. CHALBOT S, ZETTERBERG H, BLENNOW K, FLADBY T, ANDREASEN N, GRUNDKE IGBAL I, IGBAL K. 2011. Blood-cerebrospinal fluid barrier permeability in Alzheimer’s disease. J Alzheimers Dis 25: 505-515.
8. CHOPRA RN, NAYAR SL, CHOPRA IC. 1956. Glossary of Indian medicinal plants, CSIR publication, New Delhi, 330 p.
9. COE FG, ANDERSON GJ. 1996. Screening of medicinal plants used by the Garífuna of eastern Nicaragua for bioactive compounds. J Ethnopharmacol 53: 29-50.
10. DAVIDSON FF, DENNIS EA, POWELL M, GLENNEY JR. 1987. Inhibition of Phospholipase A2 by “lipocortins’ and calpactins. An effect of binding to substrate phospholipids. J Biol Chem 262: 1698-1705.
11. 2 pathway during pediatric acute respiratory distress syndrome: a preliminary study. Pediatr Crit Care Med 12: e20-e24.
12. DESSÌ M, NOCE A, BERTUCCI P, MANCA DI VILLAHERMOSA S, ZENOBI R, CASTAGNOLA V, ADDESSI E, DI DANIELE N. 2013. Atherosclerosis, Dyslipidemia, and Inflammation: The Significant Role of polyundaturated Fatty acids. ISRN Inflamm 2013: 191823.
13. DHANANJAYA BL, ZAMEER F, GIRISH KS, D’SOUZA CJ. 2011. Anti-venom potential of aqueous extract of stem bark of Mangifera indica L. against Daboia russelii (Russell`s viper) venom. Indian J Biochem Biophys 48(3): 175-183.
14. 2. Prostaglandins Leukot Essent Fatty Acids 69: 87-97.
15. 2 Enzymes. In Handbook of Venoms and Toxins of Reptiles; Mackessy SP Ed., CRC Press: Boca Raton, FL, USA, p. 173-205.
16. 2 activity: their neurochemical effects and therapeutical importance for neurological disorders. Brain Res Bull 49: 139-153.
17. GARRIDO G, GONZÁLEZ D, DELPORTE C, BACKHOUSE N, QUINTERO G, NÚÑEZ SELLÉS AJ, MORALES MA. 2001. Analgestic and anti-inflammatory effects of Mangifera indica L. Extarct (Vimang). Phytother Res 15: 18-21.
18. GARRIDO G, GONZÁLEZ D, LEMUS Y, DELPORTE C, DELGADO R. 2006. Protective effects of a standard extarct of Mangifera indica L. (VIMANG) against mouse ear edemas and its inhibition of eicosanoid production in J7774 murine macrophages. Phytomedicine 13: 412-418.
19. GARRIDO G, GONZALEZ D, LEMUS Y, GARCIA D, LODEIRO L, QUINTERO G, DELPORTE C, NUNEZ SELLES AJ, DELGADO R. 2004. In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (VIMANG). Pharmacol Res 50: 143-149.
20. GARRIDO G, RODEIRO I, HERNÁNDEZ I, GARCÍA G, PÉREZ G, MERINO N, NÚÑEZ SELLÉS A, DELGADO R. 2009. In vivo acute toxicological studies of an antioxidant extract from Mangifera indica L. (Vimang). Drug Chem Toxicol 32: 53-58.
21. 2 as multivalent mediators of inflammatory and allergic disorders. Int Arch Allergy Immunol 131: 153-163.
22. GUEVARA GM, TAMAYO BD, GONZALEZ LS, PAEZ BE, OCEGUERA J, NUNEZ SELLES AJ. 1998. Ethnopharmacologic study of Mangifera indica L. extract (QF-808). Abstract of 1st International congress pharmacology`98, ed., ORTOP, La Habana, p. 45.
23. GONZÁLEZ JE et al. 2007. Lack of in vivo embryotoxic and genotoxic activities of orally administered stem bark aqueous extract of Mangifera indica L. (Vimang). Food Chem Toxicol 45: 2526-2532.
24. KIM HP, SON KH, CHANG HW, KANG SS. 2004. Anti-inflammatory plant flavonoids and cellular action mechanism. J Pharmacol Sci 96: 229-245.
25. 2 enzymes. Toxicon 42: 827-840.
26. 2 homologues of snake venoms: Biological activities and their possible adaptive roles. Protein Pept Lett 16: 860-876.
27. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
28. 2 inhibitors for the treatment of inflammatory diseases: a patent review (2010-present). Expert Opin Ther Pat 23: 333-344.
29. MAKARE N, BODHANKAR S, RANGARI V. 2001. Immunomodulatory activity of alcoholic extract of Mangifera indica L. in mice. J Ethnopharmacol 78: 133-137.
30. 2 in cardiovascular disease: roles as biological effectors and biomarkers. Circulation 122: 2183-2200.
31. MÁRQUEZ L, GARCÍA BUENO B, MADRIGAL JL, LEZA JC. 2012. Mangiferin decreases inflammation and oxidative damage in rat brain after stress. Eur J Nutr 51: 729-739.
32. MÁRQUEZ L, PÉREZ NIEVAS BG, GÁRATE I, GARCÍA BUENO B, MADRIGAL JL, MENCHÉN L, GARRIDO G, LEZA JC. 2010. Anti-inflammatory effects of Mangifera indica L. Extract in a model of colitis. World J Gastroenterol 16: 4922-4931.
33. 2 inhibitors as potential antiinflammatory agents. Curr Pharm Des 11: 1301-1312.
34. MOHAMED R, DHARMAPPA KK, TARANNUM S, JAMEEL NM, KANNUM SA, ASHRAFULLA HS, RAI L, SOUZA CJ, SHEKHAR MA, VISHWANATH BS. 2010. Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A(2) with anti-inflammatory activity. Mol Cell Biochem 345: 69-76.
35. MOSES GS, JENSEN MD, LUE LF, WALKER DG, SUN AY, SIMONYI A, SUN GY. 2006. Secretory PLA2-IIA: a new inflammatory factor for Alzheimer`s diseases. J Neuroinflammation 3: 28.
36. 2 inhibition adn neutralization of free radicals by anti-oxidants—a new role as anti-inflammatory molecule. Curr Top Med Chem 7(8): 765-777.
37. 2 inhibitors in arachidonic acid pathway mediated inflammation and snake venom toxicity. Curr Top Med Chem 7(8): 787-800.
38. NEVALAINEN TJ, CARDOSO JC, RIIKONEN PT. 2012. Conserved domains and evolution of secreted phospholipases A(2). FEBS J 279: 636-649.
39. NUNEZ SELLES AJ, VELEZ HT, AGUERO J, GONZALEZ J, NADDEO F, DE SIMONE F, RASTRELLI L. 2002. Isolation and quantitative analysis of phenolic antioxidants, free sugars, and polyols from Mango (Mangifera indica L.) stem bark aqueous decoction used in Cuba as a nutritional supplement. J Agric Food Chem 50: 762-766.
40. OJEWOLE JA. 2005. Antiinflammatory, analgesic and hypoglycemic effects of Mangifera indica linn. (Anacardiaceae) stem-bark aqueous extract. Methods Find Exp Clin Pharmacol 27: 547-554.
41. 2 by minocycline and doxycycline. Biochem Pharmacol 44: 1165-1170.
42. ROSENSON RS, FRASER H, TRIAS J, HISLOP C. 2010. Varespladib methyl in cardiovascular disease. Expert Opin Investig Drugs 19: 1245-1255.
43. RUDRAMMAJI LM, GOWDA TV. 1998. Purification and characterization of three acidic, cytotoxic phospholipase A2 from Indian cobra (Naja naja) venom. Toxicon 36: 921-932.
44. SANCHEZ GM, RE L, GIULIANI A, NUNEZ SELLES AJ, DAVISON GP, LEON FERNANDEZ OS. 2000. Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacol Res 42: 565-573.
45. SCOTT KF, SAJINOVIC M, HEIN J, NIXDORF S, GALETTIS P, LIAUW W, DE SOUZA P, DONG Q, GRAHAM GG, RUSSELL PJ. 2010. Emerging roles for phospholipase A2 enzymes in cancer. Biochimie 92: 601-610.
46. SHAH KA, PATEL MB, PATEL RJ, PARMAR PK. 2010. Mangifera indica (mango). Pharmacogn Rev 4: 42-48.
47. SLESSER AA, BHANGU A, BOWER M, GOLDIN R, TEKKIS PP. 2013. A systemic review of anal squamous cell carcinoma in inflammatory bowel disease. Surg Oncol 22: 230-237.
48. 2 in development. Curr Pharm Des 7: 181-198.
49. 2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 45: 205-213.
50. 2 in inflammation. Adv Inflam Res 7: 51-59.
51. VANE JR, BOTTING RM. 1998. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47: 78-87.
52. VISHWANATH BS, FAWZY AA, FRANSON RC. 1988. Edema inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid. Inflammation 12: 549-561.
53. VISHWANATH BS, KINI RM, GOWDA TV. 1987. Characterization of three edema inducing phospholipase A2 enzymes from habu (Trimeresurus flavovoridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon 25: 501-515.
54. VYAS A, SYEDA K, AHMAD A, PADHYE S, SARKAR FH. 2012. Perspectives on medicinal properties of mangiferin. Mini Rev Med Chem 12: 412-425.
55. 2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudates. J Biol Chem 26: 6675-6681.
56. YAMAKAWA MM, HOKAMA NZ. 1976. Fractionation of Sakishima habu (Elegans T) venom and lethal hemorrhagic and edema forming activity of the fractions. In: Ohsaka A, Hayashi K and Sawai Y (Eds), Animal, plant and microbial toxins, Plenum Press, New York 1: 97.